Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma

Abstract Background Previous trials have suggested that elderly patients with non‐small‐cell lung cancer (NSCLC) could benefit from nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel). Real‐world data on the elderly Chinese population are lacking. This study aimed to analyze the effectiveness and...

Full description

Bibliographic Details
Main Authors: Shuhang Wang, Qiuping Liang, Yujia Chi, Minglei Zhuo, Tongtong An, Jianchun Duan, Zhijie Wang, Yuyan Wang, Jia Zhong, Xue Yang, Hanxiao Chen, Jie Wang, Jun Zhao
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Thoracic Cancer
Subjects:
Albumin‐bound paclitaxel
elderly
non‐small‐cell lung cancer
Online Access:https://doi.org/10.1111/1759-7714.13356

Internet

https://doi.org/10.1111/1759-7714.13356

Similar Items